Group 1 - The stock of Anbiping (688393) has a comprehensive score of 51.00, indicating a strong performance [1] - The main cost analysis shows the following prices: current main cost at 28.47 yuan, 5-day main cost at 28.76 yuan, 20-day main cost at 29.46 yuan [1] - The stock has experienced 2 instances of hitting the upper limit and no instances of hitting the lower limit in the past year [1] Group 2 - Short-term resistance is at 29.54 yuan, while short-term support is at 27.68 yuan [2] - The market is currently indecisive, awaiting direction from the main funds, with the mid-term trend also unclear [2] - The K-line pattern indicates a potential upward movement, with various signals suggesting different market conditions [2] Group 3 - On July 3, 2025, the net inflow of main funds was 423.99 million yuan, accounting for 9% of the total transaction volume [2] - Large orders saw a net inflow of 417.98 million yuan, while retail investors experienced a net outflow of 17.93 million yuan [2] - Related industry sectors include medical devices (0.43%), in vitro diagnostics (0.82%), and internet healthcare (0.73%) [2]
安必平(688393)每日收评(07-03)